Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGSGlobeNewsWire • Thursday
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceGlobeNewsWire • 09/06/23
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 GuidanceGlobeNewsWire • 08/09/23
Organogenesis: Solid Revenue Generation From A Hyper-Trading Wound Care CompanySeeking Alpha • 07/20/23
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023GlobeNewsWire • 07/10/23
Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of DirectorsGlobeNewsWire • 04/27/23
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023GlobeNewsWire • 04/10/23
Why Shares of Unisys, Organogenesis, and Motorcar Parts of America Fell TodayThe Motley Fool • 03/06/23
Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 GuidanceGlobeNewsWire • 03/01/23
Organogenesis Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee OsteoarthritisGlobeNewsWire • 03/01/23
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023GlobeNewsWire • 02/09/23
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Organogenesis Holdings Inc.Newsfile Corp • 01/20/23
Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech ConferenceGlobeNewsWire • 12/05/22